The Department of Social Services remains committed to exploring policy solutions that maximize health outcomes while maintaining fiscal sustainability ...

Eli Lilly is offering vials of its obesity drug Zepbound to patients at a discount — but only if they skip their insurance.

It’s no secret that weight loss drugs have exploded in popularity over the last two years, with about 12% of American adults reporting that they’ve used a medication like Ozempic, Wegovy or Mounjaro ...

Novo Nordisk (NYSE: NVO) shareholders know all about the ups and downs of pharmaceutical stock investing. From the beginning ...

Many Marylanders struggle with obesity but cannot get access to weight loss medications because insurance will not pay for ...

This month pharmacies will no longer be allowed to sell lower-cost compounded versions of the anti-obesity drug tirzepatide — ...

DexCom's growth is slowing with 2024 marking the slowest growth year in a decade and 2025 expected to follow suit with ~14% ...

WESH 2's Jason Guy and Orlando Health Weight Loss & Bariatric Surgery Institute surgeon, Dr. Muhammad Ghanem, discuss potential influences on the downward trend ...

Most obese patients grow resistant to satiety signals from the hormone leptin. A new study shows that leptin sensitivity can be restored in mice, leading to weight loss.

Insurance coverage for GLP-1 drugs remains tight despite rising demand, with more patients facing restrictions or paying out ...

Public health group warns about fake weight loss drugs ...

A product development expert explains how the swift rise of these anti-obesity medications is fueling new food trends.